Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_assertion type Assertion NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_head.
- NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_provenance.
- NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_assertion evidence source_evidence_literature NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_provenance.
- NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_assertion SIO_000772 12459031 NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_provenance.
- NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_assertion wasDerivedFrom befree-20140225 NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_provenance.
- NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_assertion wasGeneratedBy ECO_0000203 NP184487.RAOcmakAAdxXvc-1-TZ9xqsoj6LJr9dgZ5tlhGjLi3mWg130_provenance.